Lexology January 14, 2025
Ropes & Gray LLP

Life sciences licensing partner Amanda Austin moderated Ropes & Gray’s annual “From the Boardroom” panel – held in San Francisco during the 2025 J.P. Morgan Healthcare Conference – which this year looked at how companies can use deals structured as an option to obtain an exclusive license or acquisition rights to pursue valuable collaborations and pipeline opportunities while achieving balance sheet objectives.

The panel – which featured Casarine Chong, Senior Vice President, Deputy General Counsel, Transactions, Bristol Myers Squibb, Chris Frankenfield, Chief Financial Officer and Chief Operating Officer, Xilio Therapeutics, John Mayfield, Senior Vice President of Business Development & Strategy, Flagship Pioneering, and Siobhan Pomeroy, Vice President, Corporate Development, Gilead Sciences, raised a number of points that will be of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Mergers & Acquisitions / JV, Trends
Analysts Urge Caution With IPO Investors ‘Scrutinizing Deals Carefully’
Ex-FTC Chair: Private Equity Is Hurting US Health System
DirectMed Imaging acquires Richardson Healthcare, bolsters CT X-ray tube position
Iris Telehealth Rolls Out Layoffs Just After Acquiring innovaTel
How HCA is thinking of M&A in 2025

Share This Article